Arunjyoti Bio Ventures Ratios

Arunjyoti Bio Ventures Ltd Ratios

The Arunjyoti Bio Ventures Ltd Ratios page provides a complete fundamental analysis of Arunjyoti Bio Ventures Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Arunjyoti Bio Ventures Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Arunjyoti Bio Ventures Ltd (NSE: , BSE: 530881) is currently trading at ₹7.01, with a market capitalization of ₹1.31B. As a major player in the Finance sector and Financial conglomerates industry, Arunjyoti Bio Ventures Ltd remains a key stock for fundamental analysis using Arunjyoti Bio Ventures Ltd Ratios.

Arunjyoti Bio Ventures Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Arunjyoti Bio Ventures Ltd P/E ratio currently stands at 0, making it one of the most tracked metrics in Arunjyoti Bio Ventures Ltd Ratios.

Historically, the Arunjyoti Bio Ventures Ltd P/E ratio has shown strong fluctuations:

• 2024: 0
• 2023: 0
• 2022: 322.54
• 2021: 91.65

The decline in Arunjyoti Bio Ventures Ltd P/E ratio suggests improving earnings relative to stock price.

Price to Book Ratio (P/B)

The Arunjyoti Bio Ventures Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 7.71.

Historical P/B trend:

• 2024: 7.71
• 2023: 6.68
• 2022: 17.74
• 2021: 2.59

Arunjyoti Bio Ventures Ltd is trading at a premium to its book value, indicating strong market confidence.

Price to Sales Ratio (P/S)

The Arunjyoti Bio Ventures Ltd P/S ratio currently stands at 8.95, an important part of Arunjyoti Bio Ventures Ltd Ratios for revenue valuation.

Historical P/S ratio:

• 2024: 8.95
• 2023: 0.58
• 2022: 21.63
• 2021: 1.74

The rising Arunjyoti Bio Ventures Ltd P/S ratio indicates improved revenue valuation by investors.

Arunjyoti Bio Ventures Ltd Price to Cash Flow Ratio (P/CF)

The Arunjyoti Bio Ventures Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 0.

Historical Arunjyoti Bio Ventures Ltd Price to Cash Flow Ratio:

• 2024: 0
• 2023: 2.78
• 2022: 0
• 2021: 0

The declining Arunjyoti Bio Ventures Ltd Price to Cash Flow Ratio suggests improving cash flow strength.

Arunjyoti Bio Ventures Ltd Enterprise Value Ratios

Enterprise Value (EV)

The Arunjyoti Bio Ventures Ltd EV currently stands at ₹2.75B, representing the total company valuation including debt.

Historical EV trend:

• 2024: 2.75B
• 2023: 631.27M
• 2022: 697.82M
• 2021: 51.7M

Arunjyoti Bio Ventures Ltd enterprise value shows long-term growth, reflecting expansion and market confidence.

EV/EBITDA Ratio

The Arunjyoti Bio Ventures Ltd EV/EBITDA ratio is currently 54.90, a key metric in Arunjyoti Bio Ventures Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

• 2024: 54.90
• 2023: 22.79
• 2022: 0
• 2021: 0

Higher Arunjyoti Bio Ventures Ltd EV/EBITDA suggests premium valuation.

Arunjyoti Bio Ventures Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The Arunjyoti Bio Ventures Ltd D/E ratio is currently 0.81, reflecting leverage and financial stability.

Historical D/E:

• 2024: 0.81
• 2023: 29.10
• 2022: 15.26
• 2021: 0

Arunjyoti Bio Ventures Ltd maintains moderate leverage with manageable risk.

Return on Equity (ROE %)

The Arunjyoti Bio Ventures Ltd ROE currently stands at -10.67%, showing profitability and capital efficiency.

Historical ROE:

• 2024: -10.67
• 2023: -17.97
• 2022: 5.68
• 2021: 0

Declining ROE indicates pressure on profitability.

Arunjyoti Bio Ventures Ltd Ratios Analysis Summary

The Arunjyoti Bio Ventures Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Arunjyoti Bio Ventures Ltd stock is undervalued, fairly valued, or overvalued.

Tracking Arunjyoti Bio Ventures Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.